Loading clinical trials...
Loading clinical trials...
Assessment of Clozapine-related Immunodeficiency Effect in Parkinsons Disease Patients
Conditions
Interventions
blood test
Locations
1
France
CHU Amiens-Picardie
Salouël, France
Start Date
October 1, 2024
Primary Completion Date
September 1, 2027
Completion Date
September 1, 2027
Last Updated
November 19, 2025
NCT01306019
NCT02579967
NCT03610802
NCT06598397
NCT07071623
NCT00001467
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions